
|Articles|February 1, 2003
Progressive Systemic Sclerosis
Paris - Researchers at Jefferson Medical College are developing cutting edge techniques to attack the increased biosynthesis that appears to cause accumulation of collagen characteristic of scleroderma and particularly of a subset of the disease known as progressive systemic sclerosis (PSS), Jouni Uitto, M.D., Ph.D., chair, department of dermatology and cutaneous biology, said here at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
5


















